Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells

被引:300
作者
Fehniger, TA
Suzuki, K
Ponnappan, A
VanDeusen, JB
Cooper, MA
Florea, SM
Freud, AG
Robinson, ML
Durbin, J
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma 3718511, Japan
[5] Childrens Hosp, Columbus, OH 43205 USA
[6] Res Inst, Columbus, OH 43205 USA
关键词
interleukin; 15; leukemia; transgenic mice; lymphocytes; inflammation;
D O I
10.1084/jem.193.2.219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammation likely has a role in the early genesis of certain malignancies. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms. Here, we engineered a transgenic mouse to overexpress IL-15 by eliminating these posttranscriptional checkpoints. IL-15 transgenic mice have early expansions in natural killer (NK) and CD8(+) T lymphocytes. Later, these mice develop fatal lymphocytic leukemia with a T-NK phenotype. These data provide novel evidence that leukemia, like certain other cancers, can arise as the result of chronic stimulation by a proinflammatory cytokine.
引用
收藏
页码:219 / 231
页数:13
相关论文
共 52 条
  • [31] The pleiotropic functions of interleukin 15: Not so interleukin 2-like after all
    Ma, A
    Boone, DL
    Lodolce, JP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) : 753 - 755
  • [32] Role of interleukin-15 in the development of human CD56(+) natural killer cells from CD34(+) hematopoietic progenitor cells
    Mrozek, E
    Anderson, P
    Caligiuri, MA
    [J]. BLOOD, 1996, 87 (07) : 2632 - 2640
  • [33] STUDIES EVALUATING THE ANTITUMOR-ACTIVITY AND TOXICITY OF INTERLEUKIN-15, A NEW T-CELL GROWTH-FACTOR - COMPARISON WITH INTERLEUKIN-2
    MUNGER, W
    DEJOY, SQ
    JEYASEELAN, R
    TORLEY, LW
    GRABSTEIN, KH
    EISENMANN, J
    PAXTON, R
    COX, T
    WICK, MM
    KERWAR, SS
    [J]. CELLULAR IMMUNOLOGY, 1995, 165 (02) : 289 - 293
  • [34] Aggressive cutaneous NK and NK-like T-cell lymphomas - Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
    Natkunam, Y
    Smoller, BR
    Zehnder, JL
    Dorfman, RF
    Warnke, RA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (05) : 571 - 581
  • [35] Natkunam Y, 1999, AM J CLIN PATHOL, V111, P663
  • [36] Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo
    Nishimura, H
    Yajima, T
    Naiki, Y
    Tsunobuchi, H
    Umemura, M
    Itano, K
    Matsuguchi, T
    Suzuki, M
    Ohashi, PS
    Yoshikai, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) : 157 - 169
  • [37] Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
    Ogasawara, K
    Hida, S
    Azimi, N
    Tagaya, Y
    Sato, T
    Yokochi-Fukuda, T
    Waldmann, TA
    Taniguchi, T
    Taki, S
    [J]. NATURE, 1998, 391 (6668) : 700 - 703
  • [38] The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-α/β+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells
    Ohteki, T
    Yoshida, H
    Matsuyama, T
    Duncan, GS
    Mak, TW
    Ohashi, PS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) : 967 - 972
  • [39] Ohteki T, 1997, J IMMUNOL, V159, P5931
  • [40] Onu A, 1997, J IMMUNOL, V158, P255